HOUSE . . . . . . . . No. 4642
|
The Commonwealth of Massachusetts
________________________________________
HOUSE OF REPRESENTATIVES, April 11, 2022.
The committee on Public Health to whom was referred the petition (accompanied by bill, House, No. 2366) of Paul McMurtry and others for legislation to establish a special commission (including members of the General Court) relative to the bulk purchase of epinephrine auto-injectors, reports recommending that the accompanying bill (House, No. 4642) ought to pass.
For the committee,
MARJORIE C. DECKER.
FILED ON: 2/23/2022
HOUSE . . . . . . . . . . . . . . . No. 4642
|
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Second General Court
(2021-2022)
_______________
An Act relative to the bulk purchase of epinephrine auto-injectors.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Chapter 10 of the General Laws is hereby amended by inserting after section 35MMM, added by section 9 of chapter 41 of the acts of 2019, the following section:-
Section 35NNN. (a) There shall be an Epinephrine Auto-Injectors Bulk Purchase Fund. The fund shall be administered and expended by the commissioner of public health or a designee for the operation of the epinephrine auto-injectors bulk purchase program. Residents of the Commonwealth may purchase epinephrine auto-injectors directly through the program. The state office of pharmacy services shall assist with the purchasing and distribution of epinephrine auto-injectors Injectors on behalf of the program.
(b) The fund shall consist of: (i) payments made by program participants for the purchase of epinephrine auto-injectors; (ii) revenue from appropriations or other monies authorized by the general court and specifically designated to be credited to the fund; and (iii) funds from public or private sources including, but not limited to, gifts, grants, donations, rebates and settlements received by the commonwealth that are specifically designated to be credited to the fund. Amounts credited to the fund shall not be subject to further appropriation and monies remaining in the fund at the end of a fiscal year shall not revert to the General Fund.